Text Size
23 studies found for:    Open Studies | "Dengue"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Intervention:
2 Recruiting Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus;   Biological: Placebo: NaCl 0.9%
3 Recruiting West Indies-French Guiana Dengue Study
Conditions: Fever;   Dengue
Interventions: Other: biological sample collection;   Other: quality of life questionnaire EuroQol®
4 Recruiting Laboratory Diagnosis and Prognosis of Severe Dengue
Condition: Dengue Fever
Intervention:
5 Recruiting International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
Condition: Dengue Fever
Intervention: Other: Observation
6 Recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: 4 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS03B1 adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E1 adjuvant
7 Recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
Condition: Dengue Fever
Interventions: Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant;   Biological: Biological/Vaccine: 1 µg TDENV-PIV with AS03B adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E adjuvant
8 Recruiting Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Procedure: Supportive care
9 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
10 Unknown † Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
11 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Genetic: CLEC5A
12 Not yet recruiting Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine
Condition: Dengue
Interventions: Biological: dengue lyophilized vaccine;   Biological: dengue liquid vaccine;   Other: Placebo
13 Recruiting Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children
Condition: Dengue Virus Infection
Interventions: Other: Data collection;   Procedure: Blood sample collection
14 Not yet recruiting An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
Condition: Dengue Vaccines
Interventions: Procedure: Blood sample collection;   Other: Data collection
15 Recruiting Celgosivir as a Treatment Against Dengue
Condition: Dengue Fever
Interventions: Drug: celgosivir;   Drug: placebo
16 Unknown † Dengue Seroprevalence Study in Blood Donors in the French West Indies
Conditions: Blood Donors;   Dengue
Intervention: Other: Biological sample collection
17 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
18 Recruiting Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001 AM2)
Condition: Dengue
Interventions: Biological: Low-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 (non-adjuvanted);   Biological: Medium-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with Alhydrogel™ adjuvant;   Biological: High-dose V180 (non-adjuvanted);   Biological: High-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Placebo
19 Recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
20 Unknown † Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
To Top

Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results
† Indicates status has not been verified in more than two years